Martina F Mohrschladt

Severe hypertriglyceridemia with insulin resistance is associated with systemic inflammation: reversal with bezafibrate therapy in a randomized controlled trial

I.J.A.M. Jonkers, Martina F Mohrschladt, Rudi G. J. Westendorp et al. · The American Journal of Medicine · 2002 · 167 citations

Insulin Resistance, Metabolic Syndrome, Obesity +12

The neonatal heart has a relatively high content of total collagen and type I collagen, a condition that may explain the less compliant state

Monique M.H. Marijianowski, Chris M. van der Loos, Martina F Mohrschladt et al. · Journal of the American College of Cardiology · 1994 · 131 citations

Mechanobiology, Pediatric Heart Disease, Physiology +7

Hyperlipoproteinemia affects cytokine production in whole blood samples ex vivo. The influence of lipid-lowering therapy

Martina F Mohrschladt, Annelies W. E. Weverling‐Rijnsburger, Frits H.A.F. de Man et al. · Atherosclerosis · 2000 · 53 citations

Inflammation, Metabolic Syndrome, Cardiovascular Disease +11

Cardiovascular disease and mortality in statin-treated patients with familial hypercholesterolemia

Martina F Mohrschladt, Rudi G. J. Westendorp, J.A. Gevers Leuven et al. · Atherosclerosis · 2004 · 53 citations

Metabolic Syndrome, Health Policy, Cardiovascular Disease +6

TaqIB polymorphism in CETP gene: the influence on incidence of cardiovascular disease in statin-treated patients with familial hypercholesterolemia

Martina F Mohrschladt, Femke van der Sman-de Beer, M Hofman et al. · European Journal of Human Genetics · 2005 · 52 citations · Full text

Cardiovascular Epidemiology, Cardiovascular Disease, Genetics +10